More about

Peripheral Artery Disease

News
April 30, 2021
2 min read
Save

Predictive model identifies risk factors for major adverse limb events in diabetes

A risk score may be able to identify adults with type 2 diabetes at high risk for major adverse limb events, including in those without a history of peripheral artery disease, according to a study published in Diabetic Medicine.

News
April 17, 2021
1 min read
Save

Endologix acquires PQ Bypass, developer of percutaneous femoral-popliteal bypass for PAD

Endologix announced it completed the acquisition of PQ Bypass, a medical technology company that developed a platform for percutaneous femoral-popliteal bypass for severe peripheral artery disease.

News
February 17, 2021
2 min read
Save

FDA panel does not recommend approval of DCB for below-the-knee lesions

The FDA’s Circulatory System Devices Panel voted not to recommend approval of a drug-coated balloon to treat below-the-knee lesions in patients with critical limb ischemia.

News
February 12, 2021
1 min read
Save

Two studies of PCB show no excess mortality signal at 5 years

At 5 years, there was no link between a paclitaxel-coated balloon and excess mortality compared with percutaneous transluminal angioplasty in two studies of patients with peripheral artery disease.

News
February 03, 2021
1 min read
Save

Microincision vessel preparation system effective in patients with PAD

A vessel preparation system involving microincisions used before endovascular treatment for peripheral artery disease was associated with good outcomes at 1 year, researchers reported.

News
January 29, 2021
2 min read
Save

DCBs with different paclitaxel doses similar in safety, efficacy at 2 years in PAD

A low-dose paclitaxel-coated balloon was similar to a higher-dose paclitaxel-coated balloon in safety and efficacy among patients with femoropopliteal lesions at 2 years, according to new data from the COMPARE trial.

News
December 14, 2020
5 min read
Save

Pandemic underscores racial disparities in amputation; paradigm shift needed

The first thing she asked was, “Is my husband going to get to come?”

News
December 09, 2020
2 min read
Save

No mortality signal in trial paused due to paclitaxel-coated device concerns

An interim analysis of the SWEDEPAD trial, which was paused after a meta-analysis detected a mortality hazard associated with paclitaxel-coated devices, found no death risk from the devices in patients with peripheral artery disease.

News
November 21, 2020
1 min read
Save

Top news from VIVA: Drug-coated devices, treatments for PAD and more

Healio and Cardiology Today have aggregated the most-read news from the virtual VIVA 20.

News
November 20, 2020
1 min read
Save

Aspiration system for PE receives expanded indication

Penumbra announced its aspiration system to treat pulmonary embolism has received clearance for an expanded indication from the FDA.

View more